(Q43451983)

23 November 2017

0 references

Integrating clinical pharmacology concepts in individualized therapy with tyrosine kinase inhibitors (English)

1 reference

23 November 2017

1 reference

C D Drenberg

1

1 reference

23 November 2017

S D Baker

series ordinal

2

1 reference

23 November 2017

A Sparreboom

series ordinal

3

1 reference

23 November 2017

language of work or name

English

0 references

publication date

1 March 2013

1 reference

Clinical Pharmacology & Therapeutics

23 November 2017

1 reference

23 November 2017

93

1 reference

23 November 2017

215-219

1 reference

23 November 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/clpt.2012.247

23 November 2017

0 references

cites work

A history of cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.247

Protein kinases--the major drug targets of the twenty-first century?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.247

Applying the discovery of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.247

Opportunities and challenges in the development of experimental drug combinations for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.247

Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.247

Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on 4-anilinoquinazolines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.247

Pharmacokinetic considerations for new targeted therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.247

Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH-dependent solubility the Achilles heel of targeted therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.247

Environmental and genetic factors affecting transport of imatinib by OATP1A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.247

Pharmacokinetic impact of SLCO1A2 polymorphisms on imatinib disposition in patients with chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.247

Evidence for therapeutic drug monitoring of targeted anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.247

Targeting cancer with small molecule kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2012.247

21 January 2018

Identifiers

DOI

10.1038/CLPT.2012.247

1 reference

Dimensions Publication ID

23 November 2017

0 references

1 reference